Search

Michael J Hadd

from Denver, CO
Age ~48
Get Report
Also known as:
Michael Dr Hadd, Michael Joseph Hadd, Michael Padd
Related to:
Rachel Benincasa
Connected to:
Daryl Hadd, 124Jonathan A Hadd, 33Laura S Hadd, 73Linda K Hadd, 81Abdalla N Haddad, 85Adel F Haddad, 69Adil Haddad, 75Alannah Haddad, 36Aminah T Haddad, 46Andre E Haddad, 93

Michael Hadd Phones & Addresses

  • Denver, CO
  • Truckee, CA
  • San Jose, CA
  • Cedar Glen, CA
  • 2977 Bayside Ln, San Diego, CA 92109 (858) 488-4816
  • Tucson, AZ
  • San Bernardino, CA

Work

Company: Ambit biosciences Jul 2010 to Apr 2011 Position: Senior scientist ii medicinal chemistry

Education

School / High School: Uc San Diego 2011 to 2012 Specialities: Management, Design

Skills

Drug Discovery • Medicinal Chemistry • Drug Design • Patents • Clinical Trials • Clinical Development • Clinical • Lead Optimization • Organic Synthesis • Pharmaceutical Industry • Biochemistry • Drug Development • Dmpk • R&D • Lead Change • High Throughput Screening • Organic Chemistry

Languages

English

Industries

Pharmaceuticals

Resumes

Resumes

Michael Hadd Photo 1

Michael Hadd

View page
Location:
4858 Winton Way, San Jose, CA 95124
Industry:
Pharmaceuticals
Work:
Ambit Biosciences Jul 2010 - Apr 2011
Senior Scientist Ii Medicinal Chemistry
Biofocus Dpi and Discovery Partners Jun 2002 - Aug 2007
Scientist To Team Leader - Medicinal Chemistry
Education:
Uc San Diego 2011 - 2012
University of Arizona 1999 - 2001
Master of Business Administration, Masters, Business Administration, Management, Business University of Arizona 1993 - 1998
Doctorates, Doctor of Philosophy, Organic Chemistry Randolph - Macon College 1989 - 1993
Bachelors, Bachelor of Science, Business Economics, Business, Chemistry
Skills:
Drug Discovery
Medicinal Chemistry
Drug Design
Patents
Clinical Trials
Clinical Development
Clinical
Lead Optimization
Organic Synthesis
Pharmaceutical Industry
Biochemistry
Drug Development
Dmpk
R&D
Lead Change
High Throughput Screening
Organic Chemistry
Languages:
English

Business Records

Name / Title
Company / Classification
Phones & Addresses
Michael Joseph Hadd
President
Hadd Moreton Realty Inc
990 Arnold Way, San Jose, CA 95128
4510 Brighton Ave, San Diego, CA 92107

Publications

Us Patents

Spiroheterocyclic Glycosides And Methods Of Use

View page
US Patent:
7795228, Sep 14, 2010
Filed:
Dec 26, 2007
Appl. No.:
11/964493
Inventors:
Michael J. Hadd - San Diego CA, US
Yuanwei Chen - North Haven CT, US
Yan Feng - Shanghai, CN
Sengen Sen - San Diego CA, US
Brian Seed - Derry NH, US
Assignee:
Theracos, Inc. - Sunnyvale CA
International Classification:
A01N 43/04
C07H 1/00
C07H 3/00
C08B 37/00
US Classification:
514 23, 536 111
Abstract:
Provided are compounds having an inhibitory effect on sodium-dependent glucose cotransporter SGLT. The invention also provides pharmaceutical compositions, methods of preparing the compounds, synthetic intermediates, and methods of using the compounds, independently or in combination with other therapeutic agents, for treating diseases and conditions which are affected by SGLT inhibition.

Glucose Transport Inhibitors And Methods Of Use

View page
US Patent:
7803778, Sep 28, 2010
Filed:
May 22, 2007
Appl. No.:
11/752226
Inventors:
Yuanwei Chen - North Haven CT, US
Yan Feng - Shanghai, CN
Baihua Xu - Shanghai, CN
Binhua Lv - Shanghai, CN
Jiajia Dong - Shanghai, CN
Brian Seed - Derry NH, US
Michael J. Hadd - San Diego CA, US
Assignee:
Theracos, Inc. - Sunnyvale CA
International Classification:
A01N 43/04
C07H 1/00
C07H 3/00
C08B 37/00
US Classification:
514 23, 536 111
Abstract:
Provided are compounds having an inhibitory effect on sodium-dependent glucose cotransporter SGLT. The invention also provides pharmaceutical compositions, methods of preparing the compounds, synthetic intermediates, and methods of using the compounds, independently or in combination with other therapeutic agents, for treating diseases and conditions which are affected by SGLT inhibition.

Benzylic Glycoside Derivatives And Methods Of Use

View page
US Patent:
7838498, Nov 23, 2010
Filed:
Apr 1, 2008
Appl. No.:
12/060767
Inventors:
Yuanwei Chen - North Haven CT, US
Yan Feng - Shanghai, CN
Baihua Xu - Shanghai, CN
Binhua Lv - Shanghai, CN
Brian Seed - Derry NH, US
Michael J. Hadd - San Diego CA, US
Huawei Cheng - Shanghai, CN
Zelin Sheng - Belle Mead NJ, US
Min Xu - Shanghai, CN
Congna Wang - Shanghai, CN
Jiyan Du - Shanghai, CN
Lili Zhang - Shanghai, CN
Ge Xu - Shanghai, CN
Yuelin Wu - Shanghai, CN
Assignee:
Theracos, Inc. - Sunnyvale CA
International Classification:
A01N 43/04
A61K 31/70
C07H 1/00
US Classification:
514 23, 536 111
Abstract:
Provided are compounds having an inhibitory effect on sodium-dependent glucose cotransporter SGLT. The invention also provides pharmaceutical compositions, methods of preparing the compounds, synthetic intermediates, and methods of using the compounds, independently or in combination with other therapeutic agents, for treating diseases and conditions which are affected by SGLT inhibition.

Benzylbenzene Derivatives And Methods Of Use

View page
US Patent:
7838499, Nov 23, 2010
Filed:
Aug 22, 2008
Appl. No.:
12/197095
Inventors:
Yuanwei Chen - North Haven CT, US
Huawei Cheng - Shanghai, CN
Shengbin Li - Shanghai, CN
Yuelin Wu - Shanghai, CN
Yan Feng - Shanghai, CN
Binhua Lv - Shanghai, CN
Baihua Xu - Shanghai, CN
Brian Seed - Boston MA, US
Michael J. Hadd - San Diego CA, US
Yanli Song - Shanghai, CN
Jiyan Du - Shanghai, CN
Congna Wang - Shanghai, CN
Jacques Y. Roberge - Shanghai, CN
Assignee:
Theracos, Inc. - Sunnyvale CA
International Classification:
A01N 43/04
A61K 31/70
C07H 1/00
C07H 5/02
US Classification:
514 23, 536 111, 536122
Abstract:
Provided are compounds having an inhibitory effect on sodium-dependent glucose cotransporter SGLT. The invention also provides pharmaceutical compositions, methods of preparing the compounds, synthetic intermediates, and methods of using the compounds, independently or in combination with other therapeutic agents, for treating diseases and conditions which are affected by SGLT inhibition.

Benzylbenzene Derivatives And Methods Of Use

View page
US Patent:
8106021, Jan 31, 2012
Filed:
Nov 1, 2010
Appl. No.:
12/917367
Inventors:
Yuanwei Chen - North Haven CT, US
Huawei Cheng - Shanghai, CN
Shengbin Li - Shanghai, CN
Yuelin Wu - Shanghai, CN
Yan Feng - Shanghai, CN
Binhua Lv - Shanghai, CN
Baihua Xu - Shanghai, CN
Brian Seed - Boston MA, US
Michael J. Hadd - San Diego CA, US
Yanli Song - Shanghai, CN
Jiyan Du - Shanghai, CN
Congna Wang - Shanghai, CN
Jacques Y. Roberge - Shanghai, CN
Assignee:
Theracos, Inc. - Sunnyvale CA
International Classification:
A01N 43/04
A61K 31/70
US Classification:
514 23
Abstract:
Provided are compounds having an inhibitory effect on sodium-dependent glucose cotransporter SGLT. The invention also provides pharmaceutical compositions, methods of preparing the compounds, synthetic intermediates, and methods of using the compounds, independently or in combination with other therapeutic agents, for treating diseases and conditions which are affected by SGLT inhibition.

Jak Kinase Modulating Compounds And Methods Of Use Thereof

View page
US Patent:
8349851, Jan 8, 2013
Filed:
Feb 26, 2010
Appl. No.:
12/714323
Inventors:
Sunny Abraham - San Diego CA, US
Qi Chao - San Diego CA, US
Michael J. Hadd - San Diego CA, US
Mark W. Holladay - San Diego CA, US
Gang Liu - San Diego CA, US
Eduardo Setti - San Mateo CA, US
Assignee:
Ambit Biosciences Corp. - San Diego CA
International Classification:
A61K 31/517
US Classification:
51426623, 544284
Abstract:
Provided herein are quinazoline compounds of formula (I):.

Benzylbenzene Derivatives And Methods Of Use

View page
US Patent:
8575321, Nov 5, 2013
Filed:
Dec 21, 2011
Appl. No.:
13/333295
Inventors:
Yuanwei Chen - North Haven CT, US
Huawei Cheng - Pudong New District, CN
Shengbin Li - Shanghai, CN
Yuelin Wu - Pudong New District, CN
Yan Feng - Shanghai, CN
Binhua Lv - Shanghai, CN
Baihua Xu - Shanghai, CN
Brian Seed - Boston MA, US
Michael Hadd - San Diego CA, US
Yanli Song - Pudong New District, CN
Jiyan Du - Shanghai, CN
Congna Wang - Pudong New District, CN
Jacques Roberge - Shanghai, CN
Assignee:
Theracos, Inc. - Marlborough MA
International Classification:
C07H 1/00
US Classification:
536 111
Abstract:
Provided are compounds having an inhibitory effect on sodium-dependent glucose cotransporter SGLT. The invention also provides pharmaceutical compositions, methods of preparing the compounds, synthetic intermediates, and methods of using the compounds, independently or in combination with other therapeutic agents, for treating diseases and conditions which are affected by SGLT inhibition.

Quinazoline Compounds And Methods Of Use Thereof

View page
US Patent:
8633207, Jan 21, 2014
Filed:
Aug 31, 2011
Appl. No.:
13/222937
Inventors:
Michael J. Hadd - San Diego CA, US
Mark W. Holladay - San Diego CA, US
Martin Rowbottom - San Diego CA, US
Assignee:
Ambit Biosciences Corporation - San Diego CA
International Classification:
A01N 43/54
A61K 31/517
C07D 239/72
C07D 401/00
US Classification:
5142661, 544283, 544284
Abstract:
Provided herein are quinazoline compounds for treatment of JAK kinase mediated diseases, including JAK2 kinase-, JAK3 kinase- or TYK2 kinase-mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.
Control profile
Michael J Hadd from Denver, CO, age ~48 Get Report